General Information
Version
3
Revision date
2024-03-15
Product name
2-(4-hydroxybutyl)malonic acid
Emergency telephone
001-800-227-6701, +32 14 57 52 11, 001-201-796-7100, +32 14 57 52 99, 001-800-424-9300, 001-703-527-3887
Icons in SDS
Company Information
company name
Part of Thermo Fisher Scientific)
e-mail address of the competent person responsible for the Safety Data Sheet
begel.sdsdesk@thermofisher.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H315, H319, H336
Hazard statements
Code
Statements
H225
Highly flammable liquid and vapour
H315
Causes skin irritation
H319
Causes serious eye irritation
H336
May cause drowsiness or dizziness
Section 2
SECTION 2: Hazards identification
Physical hazards
Flammable liquids Category 2 (H225)
Health hazards
Skin Corrosion/Irritation Category 2 (H315) Serious Eye Damage/Eye Irritation Category 2 (H319) Specific target organ toxicity - (single exposure) Category 3 (H336) ______________________________________________________________________________________________ ALFAAZ37767 Page 1 / 10
Environmental hazards
Based on available data, the classification criteria are not met
Hazard statements
see section 16 H225 - Highly flammable liquid and vapor H315 - Causes skin irritation H319 - Causes serious eye irritation H336 - May cause drowsiness or dizziness
Signal word
Danger
Precautionary statements
P264 - Wash face, hands and any exposed skin thoroughly after handling P337 + P313 - If eye irritation persists: Get medical advice/attention P304 + P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing P312 - Call a POISON CENTER or doctor if you feel unwell P280 - Wear protective gloves/protective clothing/eye protection/face protection P303 + P361 + P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water or shower P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking
2.3 Other hazards
This product does not contain any known or suspected endocrine disruptors